-+ 0.00%
-+ 0.00%
-+ 0.00%

ASSEMBLY BIOSCIENCES - GS-1179 EXPECTED TO ADVANCE INTO PHASE 2 TRIAL FOR GENITAL HERPES BY END OF 2026

Reuters·09/08/2026 20:00:00

Please log in to view news